Wockhardt Ltd.

WOCKPHARMA Share PricePharmaceuticals & Drugs

1,331.9

-83.4 (-5.9%)

As on December 4, 2025

Exchange Scrips: BSE532300NSEWOCKPHARMAISININE049B01025

Market Cap21,706 Cr

P/E Ratio -459.09

Dividend Yield N/A

Performance

Market performance

Open1,400
High1,435.4
Volumes24,40,874
Prev1,331.9
Low1,324.1
As on2025-12-04

Historical performance

1 Year High1,868.8
3 Year High1,868.8
5 Year High1,868.8
1 Year Low1,110.05
3 Year Low145.15
5 Year Low145.15

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
21,706
Face Value
Face Value (₹)
5
P/E Ratio
P/E Ratio
-459.09
Dividend Yield
Dividend Yield
N/A

Investment Returns

1 Year
-7.4%
3 Years
446.5%
5 Years
226.8%
10 Years
-13.8%

Technicals

IndicatorsValueSignal
5-DMA1,389.84Bearish
10-DMA1,338.08Bearish
20-DMA1,341.63Bearish
50-DMA1,370.58Bearish
100-DMA1,469.86Bearish
200-DMA1,453.09Bearish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters1414141413
Foreign Investors---------------
Domestic Investors1414141413
Public Investors137932146904141785142696138129
Government11111

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -459.09.
  • 3Y Stock Price CAGR of the stock is 78.0.
  • The stock has a beta of 1.6.
  • In the last financial year, the company had an EBITDA of ₹4550 Million.
  • The company generated revenue of ₹30120 Million in the previous financial year.

Wockhardt Ltd.

1331.9-83.4   (-5.9%)

Investment Amount: ₹ 1000000
Current Value: ₹ 929059.7
No. of Shares: 698 (Approx)
Performance:-7.1%
P/L: ₹-70940.3

Top Gainers

SymbolChange%
SMCGLOBAL73.48(20%)
MAGNUM24.77(19%)
TOTAL86.05(17%)
NECLIFE20.94(17%)
ELDEHSG951(14%)

Top Losers

SymbolChange%
EMMVEE219.86(-9%)
POWERINDIA20085(-8%)
DAVANGERE3.87(-8%)
ONMOBILE58.3(-7%)
DUCON3.67(-7%)
BEDMUTHA101.23(-7%)
AVG176.08(-6%)
KAYNES4978(-6%)

Peer Comparison

Venus Remedies Ltd.

72.4%

764.15

1 Month Performance

Nectar Lifesciences Ltd.

49.5%

20.94

1 Month Performance

Ortin Global Ltd.

26.9%

14.49

1 Month Performance

Natco Pharma Ltd.

15.8%

949.25

1 Month Performance

SMS Pharmaceuticals Ltd.

14.8%

322.45

1 Month Performance

Ipca Laboratories Ltd.

12.3%

1454.6

1 Month Performance

Haleos Labs Ltd.

11.4%

1315.1

1 Month Performance

Gufic Biosciences Ltd.

9.5%

358.15

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month